Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies
Qingfu Dong, Haolin Bao, Jiangang Wang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 11

Showing 11 citing articles:

Emerging advanced approaches for diagnosis and inhibition of liver fibrogenesis
Tamer A. Addissouky, Majeed M. A. Ali, Ibrahim El Tantawy El Sayed, et al.
The Egyptian Journal of Internal Medicine (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 9
Tyrosol attenuates NASH features by reprogramming the hepatic immune milieu
Daniela Gabbia, Katia Sayaf, Ilaria Zanotto, et al.
European Journal of Pharmacology (2024) Vol. 969, pp. 176453-176453
Open Access | Times Cited: 5
MAFLD Pandemic: Updates in Pharmacotherapeutic Approach Development
Farah Khaznadar, Omar Khaznadar, Ana G. Petrovic, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 6300-6314
Open Access | Times Cited: 4
AlphaFold-Based AI Docking Reveals AMPK/SIRT1-TFEB Pathway Modulation by Traditional Chinese Medicine in Metabolic-Associated Fatty Liver Disease
Lulu Zhang, Yi Zheng, Mingyan Shao, et al.
Pharmacological Research (2025), pp. 107617-107617
Open Access
Diagnosis, Prognosis, and Treatment of Triple-Negative Breast Cancer: A Review
Huan Jie, Wenhui Ma, Cong Huang
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 265-274
Open Access
The role of TRIM family in metabolic associated fatty liver disease
Jingyue Zhang, Ying‐Ming Zhang, Ze Ren, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
MAFLD Pandemic: Updates in Pharmacotherapeutic Approach Development
Farah Khaznadar, Omar Khaznadar, Ana G. Petrovic, et al.
(2024)
Open Access | Times Cited: 1
Anti-Inflammatory Oxysterol, Oxy210, Inhibits Atherosclerosis in Hyperlipidemic Mice and Inflammatory Responses of Vascular Cells
Frank Stappenbeck, Feng Wang, Satyesh K. Sinha, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1632-1632
Open Access | Times Cited: 1
Prevalence, determinants, and fibrosis risk stratification of metabolic-associated fatty liver disease in a Turkish primary care setting: A retrospective study
Ayse Yazan Arslan, Sultannur Celik, Fatuhulah Amin, et al.
Hepatology forum/Hepatology forum (Online) (2023), pp. 63-67
Open Access | Times Cited: 2
Prevalence of MAFLD in the U.S. Based on NHANES 2009-2018: Differences in Demographic Characteristics, Physical Indices and Lifestyle Conditions
Dan Ye, Jiaofeng Wang, Jiaheng Shi, et al.
Research Square (Research Square) (2024)
Open Access
Magnetic resonance spectroscopy as a diagnostic model for assessment of liver steatosis in metabolic dysfunction-associated steatotic liver disease in non-diabetic patients
Sarah El-Nakeep, Enas Foda, Aliaa Sayed Sheha, et al.
The Egyptian Journal of Radiology and Nuclear Medicine (2024) Vol. 55, Iss. 1
Open Access
A screening study of high-risk groups for liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
Guanqun Chao, Zhu Feng Yue, Yang Bao
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Page 1

Scroll to top